CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $907,800 | -46.1% | 20,000 | -33.3% | 0.00% | -66.7% |
| Q2 2023 | $1,684,200 | -69.0% | 30,000 | -75.0% | 0.01% | -50.0% |
| Q1 2023 | $5,427,600 | +63.6% | 120,000 | +47.1% | 0.02% | -29.4% |
| Q4 2022 | $3,317,040 | +238.5% | 81,600 | +444.0% | 0.03% | +277.8% |
| Q3 2022 | $980,000 | +7.5% | 15,000 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $912,000 | -58.5% | 15,000 | -57.1% | 0.01% | -76.7% |
| Q1 2022 | $2,197,000 | +22.3% | 35,000 | +47.7% | 0.03% | +66.7% |
| Q4 2021 | $1,796,000 | -8.3% | 23,700 | +35.4% | 0.02% | -33.3% |
| Q3 2021 | $1,959,000 | +61.4% | 17,500 | +133.3% | 0.03% | +80.0% |
| Q2 2021 | $1,214,000 | -33.6% | 7,500 | -50.0% | 0.02% | -34.8% |
| Q1 2021 | $1,828,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |